Active substance
Zuclopenthixol
- SFDA 11
- Health Canada 4
- NHS prices 6
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CLOPIXOL DEPOT INJ 200MG-ML | 200 mg/ml | Injection · Intramuscular use | 10 Ampoule | SAR 168.20 | NCE · Prescription | H. LUNDBECK | Valid |
| CLOPIXOL DEPOT INJ 500MG-ML OILY AMP | 500 mg/ml | Injection · Intramuscular use | 5 Ampoule | SAR 231.95 | NCE · Prescription | H. LUNDBECK | Valid |
| CLOPIXOL-ACUPHASE 50MG-ML OILY AMP | 50 mg/ml | Injection · Intramuscular use | 1 Ampoule | SAR 8.05 | NCE · Prescription | H. LUNDBECK | Valid |
| CLOPIXOL-ACUPHASE 50MG-ML OILY AMP | 50 mg/ml | Injection · Intramuscular use | 1 Ampoule | SAR 16.10 | NCE · Prescription | H. LUNDBECK | Valid |
| CLOPIXOL DROPS 2% | 2 % | Oral drops, solution · Oral use | 1 Bottle | SAR 31.55 | NCE · Prescription | H. LUNDBECK | Withdrawn by MAH · Not Marketed |
| CLOPIXOL INJ 10MG-ML | 10 mg/ml | Solution · Intramuscular use | 10 Ampoule | SAR 33.65 | NCE · Prescription | H. LUNDBECK | Invalid · Not Marketed |
| CLOPIXOL TABS 10MG | 10 mg | Tablet · Oral use | 50 Tablet Container | SAR 28.85 | NCE · Prescription | H. LUNDBECK | Invalid · Not Marketed |
| CLOPIXOL TABS 10MG | 10 mg | Tablet · Oral use | 100 Tablet Container | SAR 77.15 | NCE · Prescription | H. LUNDBECK | Withdrawn by MAH · Not Marketed |
| CLOPIXOL TABS 25MG | 25 mg | Tablet · Oral use | 50 Tablet Container | SAR 52.95 | NCE · Prescription | H. LUNDBECK | Invalid · Not Marketed |
| CLOPIXOL TABS 25MG | 25 mg | Tablet · Oral use | 100 Tablet Container | SAR 94.60 | NCE · Prescription | H. LUNDBECK | Withdrawn by MAH · Not Marketed |
| CLOPIXOL TABS 2MG | 25 mg | Tablet · Oral use | 100 Tablet Container | SAR 17.60 | NCE · Prescription | H. LUNDBECK | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
SCHIZOPHRENIA
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CLOPIXOL | 02230402 | 10 MG | TABLET · ORAL | LUNDBECK CANADA INC |
| CLOPIXOL | 02230403 | 25 MG | TABLET · ORAL | LUNDBECK CANADA INC |
| CLOPIXOL ACUPHASE | 02230405 | 50 MG / ML | SOLUTION · INTRAMUSCULAR | LUNDBECK CANADA INC |
| CLOPIXOL DEPOT | 02230406 | 200 MG / ML | SOLUTION · INTRAMUSCULAR | LUNDBECK CANADA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Zuclopenthixol 10mg tablets | £8.06 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Zuclopenthixol 25mg tablets | £16.13 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Zuclopenthixol 2mg tablets | £3.14 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Zuclopenthixol acetate 50mg/1ml solution for injection ampoules | £24.21 | 5 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Zuclopenthixol decanoate 200mg/1ml solution for injection ampoules | £31.51 | 10 ampoule | 1 Oct 2026 |
| NHS Drug Tariff | Zuclopenthixol decanoate 500mg/1ml solution for injection ampoules | £37.18 | 5 ampoule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 24.1. Medicines for psychotic disorders · core
Therapeutic equivalent to fluphenazine for Schizophrenia or other primary psychotic disorders
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.